心血管デバイスの日本市場 - 市場規模、シェア、動向、予測：デバイスタイプ別、用途別、エンドユーザー別、地域別、2025年～2033年

日本の心血管デバイス市場規模は2024年に330万米ドルに達しました。今後、IMARC Groupは、同市場は2033年までに701万米ドルに達し、2025～2033年の成長率（CAGR）は8.08％になると予測しています。市場は高齢化、心血管疾患の増加、技術の進歩によって牽引されます。主要セグメントには、ペースメーカー、ステント、モニタリング機器などがあります。政府の取り組みと医療投資の増加が市場の成長を支える一方、規制政策が製品の承認と採用に影響を与えます。

本レポートで扱う主な質問

• 日本の心血管デバイス市場はこれまでどのように推移し、今後どのように推移するのか？
• 日本の心血管デバイス市場のデバイスタイプ別区分は？
• 日本の心血管デバイス市場の用途別区分は？
• 日本の心血管デバイス市場のエンドユーザー別区分は？
• 日本の心血管デバイス市場のバリューチェーンにおける様々なステージとは？
• 日本の心血管デバイスの主要な促進要因と課題は何か？
• 日本の心血管デバイス市場の構造と主要プレーヤーは？
• 日本の心血管デバイス市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の心血管デバイス市場 - イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の心血管デバイス市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本の心血管デバイス市場 - デバイスタイプ別内訳

• 診断・モニタリング用デバイス
• 治療・手術用デバイス

第7章 日本の心血管デバイス市場 - 用途別内訳

• 冠動脈疾患（CAD）
• 不整脈
• 心不全
• その他

第8章 日本の心血管デバイス市場 - エンドユーザー別内訳

• 病院
• 専門クリニック
• その他

第9章 日本の心血管デバイス市場 - 競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の心血管デバイス市場 - 業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

The Japan cardiovascular devices market size reached USD 3.30 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7.01 Million by 2033, exhibiting a growth rate (CAGR) of 8.08% during 2025-2033. The market is driven by an aging population, rising cardiovascular diseases, and technological advancements. Key segments include pacemakers, stents, and monitoring devices. Government initiatives and increasing healthcare investments support market growth, while regulatory policies influence product approvals and adoption.

Japan Cardiovascular Devices Market Trends:

Rising Demand for Minimally Invasive Cardiovascular Procedures

Japan is facing a higher demand for minimally invasive (MI) cardiovascular devices owing to an aging population and improved catheter-based treatments. The adoption of transcatheter aortic valve replacement (TAVR) and percutaneous coronary interventions (PCI) is rising, reducing hospital stays and accelerating recovery. Japanese medical device companies are investing in robotics-assisted procedures and next-generation catheters to improve precision. The regulatory environment, under the guidance of the Pharmaceuticals and Medical Devices Agency (PMDA), is making approval easier for groundbreaking technologies, permitting quicker market entry. Furthermore, artificial intelligence (AI) is improving the precision of cardiovascular imaging diagnostics, aiding early intervention protocols. For example, in September 2024, Japan-based Cardio Intelligence introduced SmartRobin AI, an ECG monitoring system powered by explainable AI for fast atrial fibrillation detection, enhancing stroke risk assessment and diagnostic accuracy in cardiovascular care. Additionally, with home healthcare being supported by the government, remote monitoring devices such as wearable ECGs and implantable loop recorders are also becoming popular. The trend is in support of Japan's value-based medicine drive, stressing cost-effectiveness and patient outcome. With shifting reimbursement policies, the market can anticipate increased growth in minimally invasive cardiovascular solutions.

Growth of AI-Integrated Cardiovascular Diagnostics

AI is transforming cardiovascular diagnostics in Japan, improving early disease detection and predictive analytics. AI-driven echocardiography and computed tomography (CT) imaging machines are enabling faster, more accurate diagnosis of heart disease. Large research centers and hospitals are applying AI in real-time monitoring of the heart, reducing the burden on healthcare personnel. ML technologies are being integrated into electronic health records (EHRs) for predicting risks of heart failure, allowing preventive treatment modalities. The focus on digital health innovation in Japan is inducing collaborations between medtech firms and AI startups to accelerate the deployment of intelligent diagnostic equipment. The government drive in personalized medicine is also driving AI-enabled cardiovascular care so that precise treatment plans are delivered based on gene and lifestyle factors. As AI reduces diagnostic errors and increases workflow efficiency, its use in cardiovascular devices is increasing, leading to improved patient management and long-term healthcare cost savings. For instance, in September 2024, Olympus launched VISERA S, an all-in-one imaging platform with NBI and stroboscopy, across Europe, Asia, and Oceania, enhancing ENT diagnostics with improved visualization and streamlined workflow.

Expansion of Wearable and Remote Cardiac Monitoring Devices

Wearable and remote cardiac monitoring devices are gaining quick adoption in Japan, fueled by the increasing age population and the rising incidence of heart diseases. Smartwatches with built-in ECG, hand-carried Holter monitors, and implantable cardiac event recorders are becoming cornerstones of preventive cardiology. The emergence of 5G connectivity is accelerating real-time data transmission, allowing doctors to monitor patients remotely and catch anomalies before critical events. Japanese device makers are creating small, easy-to-use wearables with longer battery life to drive patient compliance. PMDA support is driving speedy approvals of cutting-edge telemedicine solutions as the nation accelerates healthcare digitalization. Insurers are starting to reimburse for remote monitoring services, further driving market expansion. As clinics and hospitals implement cloud-based cardiac monitoring systems, data-driven information is maximizing treatment plans, lowering hospital readmissions, and enhancing patient outcomes in Japan's changing cardiovascular care environment.

Japan Cardiovascular Devices Market Segmentation:

Device Type Insights:

• Diagnostic and Monitoring Devices
  • Electrocardiogram (ECG)
  • Remote Cardiac Monitoring
  • Others
• Therapeutic and Surgical Devices
  • Cardiac Rhythm Management (CRM) Devices
  • Catheter
  • Stents
  • Heart Valves
  • Others

Application Insights:

• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

End User Insights:

• Hospitals
• Specialty Clinics
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan cardiovascular devices market performed so far and how will it perform in the coming years?
• What is the breakup of the Japan cardiovascular devices market on the basis of device type?
• What is the breakup of the Japan cardiovascular devices market on the basis of application?
• What is the breakup of the Japan cardiovascular devices market on the basis of end user?
• What are the various stages in the value chain of the Japan cardiovascular devices market?
• What are the key driving factors and challenges in the Japan cardiovascular devices?
• What is the structure of the Japan cardiovascular devices market and who are the key players?
• What is the degree of competition in the Japan cardiovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cardiovascular Devices Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Cardiovascular Devices Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Cardiovascular Devices Market - Breakup by Device Type

• 6.1 Diagnostic and Monitoring Devices
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Segmentation
    • 6.1.3.1 Electrocardiogram (ECG)
    • 6.1.3.2 Remote Cardiac Monitoring
    • 6.1.3.3 Others
  • 6.1.4 Market Forecast (2025-2033)
• 6.2 Therapeutic and Surgical Devices
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Segmentation
    • 6.2.3.1 Cardiac Rhythm Management (CRM) Devices
    • 6.2.3.2 Catheter
    • 6.2.3.3 Stents
    • 6.2.3.4 Heart Valves
    • 6.2.3.5 Others
  • 6.2.4 Market Forecast (2025-2033)

7 Japan Cardiovascular Devices Market - Breakup by Application

• 7.1 Coronary Artery Disease (CAD)
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Cardiac Arrhythmia
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Heart Failure
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Others
  • 7.4.1 Historical and Current Market Trends (2019-2024)
  • 7.4.2 Market Forecast (2025-2033)

8 Japan Cardiovascular Devices Market - Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Specialty Clinics
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Others
  • 8.3.1 Historical and Current Market Trends (2019-2024)
  • 8.3.2 Market Forecast (2025-2033)

9 Japan Cardiovascular Devices Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Services Offered
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Services Offered
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Services Offered
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Services Offered
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Services Offered
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Cardiovascular Devices Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix